Page Contents

The Mergers & Acquisitions (“M&A”) Advisory team at NBK Capital provides strategic financial advice to middle-market and blue chip companies across the MENA region. The team delivers optimal and actionable solutions to clients across all sectors.

On-the-ground team with local knowledge and extensive global experience source proprietary deals, while aligning incentives with client success and ensuring execution at the highest standards.

The team’s wide network, rooted in blue chip and middle-market companies, private equity firms, established investment institutions, and high net worth individuals, allows it to tailor creative solutions to its clients.

Since inception, the M&A Advisory team successfully closed transactions worth more than USD 6.7 billion.

Mergers & Acquisitions Advisory Services

  • Sell-side and Buy-side Advisory
  • Mergers
  • Corporate Restructuring
  • Diversities/Carve-outs
  • Portfolio Analysis

Highlights

The M&A Advisory team’s track record highlights broad reach, expansive capabilities and extensive experience

  • Landmark Transactions
    The team advised on significant regional bank acquisitions including the National Bank of Kuwait’s acquisition of Al-Watany Bank of Egypt and National Commercial Bank’s acquisition of 60% of Turkiye Finans.
  • Cross-border Expertise
    With local expertise and regional reach, the team was the advisor of choice for both cross-border acquisitions by Ooredoo and Saudi Telecom Company of telecommunications players in Kuwait, with both tender offers totaling USD 2.2 billion.
  • Long-standing Relationships
    Having cultivated deep relationships with blue chip companies in the region, the team regularly advises such companies in growth, expansion and divesture transactions, such as Mezzan Holding Co.’s acquisition of Unitra Mets Group and Kuwait Telecommunications Company’s acquisition of Qualitynet.
  • Middle-market Dominance
    Showcasing its middle-market dominance, the team is consistently involved in the segment’s activities, having most recently advised on the sale of a minority stake in Taiba Hospital and the sale of Multibrands.

Select Transactions

  • All figures are as of 30 June 2021

  • img

    Denotes an award-winning transaction